Indefinite Delivery Contract SPE2DR25D9348

The Defense Logistics Agency (DLA) has awarded a $4,999,999 single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

This IDC, which is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V, covers a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. The contract has a base period of 30 months and three 30-month option periods, with an estimated total value of $30.3 billion for the entire procurement. DMS Pharmaceutical Group, as a key supplier in the federal pharmaceutical supply chain, will leverage its status as a woman-owned small business to deliver these critical pharmaceutical products and services to the Department of Defense and other government agencies.